Product Images Nabumetone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Nabumetone NDC 66336-316 by Dispensing Solutions, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
COOH and CH40 are not recognizable text and may contain errors or non-English characters. 6-methoxy-2-naphthylacetic acid (6MNA) is a chemical compound that belongs to the class of naphthalenes. It is an acetic acid derivative that contains a naphthalene ring system and a methoxy group at position 6. It is commonly used as an anti-inflammatory and analgesic agent in the treatment of various disorders, including osteoarthritis, rheumatoid arthritis, and menstrual pain.*
This is a graph showing the plasma concentrations of the active metabolite of Nabumetone (6MNA) at steady state following once-daily dosing of either 1000 mg (n=31) or 2000 mg (n=12) of Nabumetone. The x-axis represents the time in hours and the y-axis represents the plasma concentration in ng/mL. The graph displays two lines for each dosage, displaying the 2SD and +2SD for 1000mg and the 2SD for 2000mg respectively.*
This is a report on the distribution of different forms of nabumetone metabolites in a sample, expressed as a percentage of total dose. The sample contained several forms of 6-methoxy-2-naphthylacetic acid (6MNA), 6-hydroxy-2-naphthylacetic acid (6HNA), and 4-(6-hydroxy-2-naphthyl)-butan-2-ol, in both conjugated and unchanged form. Additionally, there was an unidentified minor metabolite present. The percentage of each individual form of metabolites varied, with the majority of the sample being in the conjugated form of 6HNA.*
This table shows the Mean/Mode Duration of treatment for patients with RA who are taking different doses of Nabumetone over a period of years. The results are reported in milligrams (mg) with varying number of patients for each dose.*
This text provides a list of serious and other side effects associated with the use of a medication. The serious side effects listed include heart attack, stroke, high blood pressure, kidney failure, liver failure, and life-threatening skin and allergic reactions. Other possible side effects include stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*
This text describes different symptoms that could be related to a medical emergency or condition. These symptoms include shortness of breath or trouble breathing, slurred speech, chest pain, swelling of the face or throat, and weakness in one part or side of your body. It's important to seek medical attention if you experience any of these symptoms.*
This text appears to be a list of symptoms that may indicate potential medical problems. Symptoms listed include nausea, fatigue, itching, yellowing of skin or eyes, stomach pain, flu-like symptoms, vomiting blood, blood in bowel movements or black, tar-like appearance of bowel movements, unusual weight gain, skin rash or blisters with fever, and swelling of arms, legs, hands and feet. These symptoms may be indicative of serious medical conditions, and medical attention should be sought if experiencing any of them.*
This text provides a list of generic names and their corresponding trade names of various pain-relieving medications such as Celebrex, Cataflam, Voltaren, Dolobid, Lodine, Nalfon, Ansaid, and others.*
This is a description of bulk source data for Nabumetone 500mg tablets. The manufacturer's name is Invagen Pharmaceuticals, and the product is identified with a white, oval-shaped, film-coated biconvex tablet debossed with IG/257. The bulk source NDC is 68462-0358-05, and the manufacturer's lot is 00000. The product should be dispensed in a tight/light-resistant container and taken orally every few hours as needed with food but avoiding alcohol. The text includes warnings about avoiding the reach of children, storing at 68°- 77° F, and potential side effects such as dizziness. The medication guide should be included in dispensing. The package was exclusively by VTS Solutions in Santa Ana, CA with an expiration date of 00-00 and RX number 23829272.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.